Cetirizine Hydrochloride / Pseudoephedrine Hydrochloride
Pronunciation: (se-TIR-i-zeen HYE-droe-KLOR-ide/SOO-doe-e-FED-rin HYE-droe-KLOR-ide)Class: Upper respiratory combinations
Trade Names:
Zyrtec-D 12 Hour
- Tablets, extended-release cetirizine hydrochloride 5 mg/pseudoephedrine hydrochloride 120 mg
Indications and Usage
Relief of nasal and non-nasal symptoms associated with seasonal or perennial allergic rhinitis.
Contraindications
Narrow-angle glaucoma; urinary retention; severe hypertension; severe coronary artery disease; patients receiving MAOIs or within 14 days of stopping such treatment; hypersensitivity to any component of the product, adrenergic agents, or other drugs of similar chemical structure; manifestations of patient idiosyncrasy to adrenergic agents, including arrhythmias, dizziness, insomnia, tremor, or weakness.
Dosage and Administration
Adults and children 12 yr of age and olderPO One 12-h tablet (cetirizine 5 mg/pseudoephedrine 120 mg) twice daily.
Hepatic or Renal Function ImpairmentAdults and children 12 yr of age and older
PO One 12-h tablet (cetirizine 5 mg/pseudoephedrine 120 mg) once daily in patients on hemodialysis (Ccr less than 7 mL/min), with hepatic function impairment, or with decreased renal function (Ccr 11 to 31 mL/min).
General Advice
- May be taken with or without food.
- Patients must swallow extended-release tablet whole and not break or chew.
Storage/Stability
Store at 68° to 77°F.
Drug Interactions
Antihypertensive agents that interfere with sympathetic activity (eg, mecamylamine, methyldopa, reserpine)Antihypertensive effects of these agents may be reduced.
DigitalisIncreased ectopic pacemaker activity.
MAOIs (eg, phenelzine)Coadministration is contraindicated with pseudoephedrine and for 14 days after stopping the MAOI.
Sympathomimetic aminesAdditive or potentiated effects on the CV system.
Laboratory Test Interactions
Positive reactions to skin tests may be prevented or diminished.
Adverse Reactions
CNS
Insomnia (4%); fatigue, somnolence (2%); dizziness (1%).
EENT
Pharyngitis (2%); epistaxis (1%).
GI
Dry mouth (4%).
Respiratory
Sinusitis (1%).
Miscellaneous
Accidental injury (1%).
Precautions
Pregnancy
Category C .
Lactation
Both ingredients are excreted in breast milk.
Children
Safety and efficacy not established in children younger than 12 yr of age.
Elderly
Use with caution, usually starting at the low end of the dosage range, because of the greater frequency of decreased hepatic, renal, or cardiac function, and concomitant diseases or other drug therapy.
Special Risk Patients
Use with caution in patients with diabetes mellitus, hypertension, hyperthyroidism, increased IOP, ischemic heart disease, prostatic hypertrophy, or renal function impairment.
Cognitive and motor impairment
Caution patients about operating potentially hazardous machinery (eg, driving) until they know whether the drug impairs their ability. Avoid use of alcohol.
Overdosage
Symptoms
CetirizineDrowsiness, irritability, somnolence.
PseudoephedrineAnxiety, cardiac arrhythmias, circulatory collapse, coma, convulsions, difficulty in micturition, giddiness, headache, insomnia, muscular weakness, nausea, palpitations, precordial pain, respiratory failure, restlessness, sweating, tachycardia, tenseness, thirst, toxic psychosis with delusions and hallucinations, vomiting.
Patient Information
- Instruct patient regarding how to store, administer, and dispose of outdated medication.
| Link to Page | Print Page | Email Page | Add to List |
More Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride resources
Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride Side Effects
cetirizine/pseudoephedrine Drug Interactions
Compare Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride with other medications for the treatment of:
User reviews
2 review(s) for Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride
